SCHEMBL1675141

SCHEMBL1675141

Cc1ccc(CN(C)c2ncnc3ccc(-c4ccc(C(=O)O)o4)cc23)o1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 16/20 0.66
CLK1 P49759 6/20 0.66
CLK2 P49760 4/20 0.66
DYRK1B Q9Y463 4/20 0.66
CDK2 P24941 1/20 0.61
DYRK1A Q13627 2/20 0.54
CYP1A2 P05177 10/20 0.48
CYP3A4 P08684 10/20 0.48
CYP2D6 P10635 10/20 0.48
CYP2C19 P33261 10/20 0.48
TSHR P16473 9/20 0.48
LMNA P02545 8/20 0.48
USP2 O75604 7/20 0.48
ALDH1A1 P00352 6/20 0.48
HSD17B10 Q99714 5/20 0.48
MAPK1 P28482 5/20 0.48
HIF1A Q16665 3/20 0.48
CYP2C9 P11712 2/20 0.45
TP53 P04637 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1675242 0.89 CLK1 (0.73) CLK4CLK1CLK2DYRK1BCDK2
SCHEMBL1675160 0.86 CLK4 (0.71) CLK4CLK1CLK2DYRK1BCDK2
SCHEMBL1675133 0.84 CLK4 (0.60) CLK4CLK1CLK2DYRK1BCDK2
SCHEMBL1675131 0.79 CLK4 (1.00) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675146 0.76 CLK4 (0.50) CLK4CLK1CLK2DYRK1BCDK2
SCHEMBL1675262 0.76 CDK2 (1.00) CLK4CLK1CLK2DYRK1BCDK2
SCHEMBL1675096 0.75 CLK4 (0.49) CLK4CLK1CLK2DYRK1BCDK2
SCHEMBL1675109 0.75 CLK4 (0.49) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675289 0.75 CDK2 (0.59) CLK4CLK1CLK2DYRK1BCDK2
SCHEMBL1675079 0.75 CLK1 (0.80) CLK4CLK1CLK2DYRK1BCDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO claimed
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO disclosed